Abstract:Oral squamous cell carcinoma (OSCC) is one of the most lethal malignancies which accounts for approximately 90% of all malignant oral tumours. SAMMSON is a lncRNA located on chromosome 3p13–3p14 and is known to act as an oncogene in several malignancies. However, its expression and clinical significance in oral squamous cell carcinoma (OSCC) remain mostly unclear. In this study, we investigated the expression and clinical relevance of lncRNA SAMMSON in human OSCC.Human OSCC cell lines (Tca8113, SCC9, SCC25, CAL27, HN12, HSU3, FADU) and a human normal oral keratinocyte cell line (HNOK) were used to detect the difference of SAMMSON expression. A total of 90 OSCC patients confirmed by pathological and clinical diagnoses at the Hospital of Stomatology, Department of Periodontology, Shandong University were enrolled. The mRNA expression level was analyzed by reverse transcription PCR (QRT-PCR). Statistical analyses including Student's t-test, chi-square method, Kaplan-Meier method, Univariate and, Multivariate Cox regression analysis were performed to analyse all data.This study showed that the expression of SAMMSON was significantly increased in OSCC tissues and cell lines. High SAMMSON expression was significantly associated with TMN stage, tumour differentiation, lymph node metastasis distant metastasis and neighboring tissue infiltration. Patients with high expression of SAMMSON had poor overall survival and disease-free survival compared to those with low levels. Cox regression analysis showed that SAMMSON could act as an independent prognostic factor in OSCC.Serum SAMMSON expression was associated with tumour SAMMSON expression. ROC curve analysis indicated the high diagnostic sensitivity and specificity of serum SAMMSON expression in OSCC patients as compared to other traditional serum biomarker SCCA, TSGF, and CEA. These results indicated that SAMMSON might play an essential role in OSCC progression and could serve as a novel prognostic and diagnostic biomarker in OSCC.

Overexpression and cytoplasmic localisation of Sam68 correlates with tumour progression and poor prognosis in patients with clinically N0 oral tongue cancer

Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma

Retraction Note To: High Expression Level and Nuclear Localization of Sam68 Are Associated with Progression and Poor Prognosis in Colorectal Cancer

Sam68 Expression and Cytoplasmic Localization is Correlated with Lymph Node Metastasis As Well As Prognosis in Patients with Early-Stage Cervical Cancer.

High Sam68 expression predicts poor prognosis in non-small cell lung cancer

Sam68 Reduces Cisplatin-Induced Apoptosis in Tongue Carcinoma

Sam 68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancer

The Rna-Binding Protein Sam68 Is Critical For Non-Small Cell Lung Cancer Cell Proliferation By Regulating Wnt/Beta-Catenin Pathway

Sam68 Up-Regulation Correlates With, and Its Down-Regulation Inhibits, Proliferation and Tumourigenicity of Breast Cancer Cells

Sox2 Nuclear Expression is Closely Associated with Poor Prognosis in Patients with Histologically Node-Negative Oral Tongue Squamous Cell Carcinoma

Overexpression of metabolic markers PKM2 and LDH5 correlates with aggressive clinicopathological features and adverse patient prognosis in tongue cancer

High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer.

High expression of Sam68 in sacral chordomas is associated with worse clinical outcomes.

Correlation of ALDH1, CD44, OCT4 and SOX2 in Tongue Squamous Cell Carcinoma and Their Association with Disease Progression and Prognosis.

GOLPH3 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Clinically N0 Oral Tongue Cancer

Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer.

Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma

FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma

Utility of SAM68 in the progression and prognosis for bladder cancer

Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients

Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue]